Clinical Trial Search - Maternal GBS Vaccine - CPL (US) {Ages 18-49}
$7.50 CPLactive✓ verified live 8h ago
MaxBounty · Health & Wellness / General Wellness · US · live 22 days · compare this product across geos & networks →
Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.
Run this offer — join MaxBounty →
Should you run this?
- 💸 This product pays more elsewhere: $225.00 on MaxBounty (US) — 2900% more than this listing (different geo, same network). All 21 versions →
- ⚖️ Payout vs its vertical: beats 6% of the 3614 live Health & Fitness offers we track (vertical median $26.00).
- 🛡️ Stability: Payout unchanged since we started tracking it 22 days ago.
Payout history
Description
This clinical research study evaluates an investigational vaccine designed to prevent invasive Group B Streptococcus (GBS) disease in infants. Participants undergo a comprehensive 21-month program including physical exams, laboratory tests, and e-diary monitoring to assess vaccine efficacy and safety.
Converts on successful completion of the medical screener and lead submission.
Targeting: Pregnant females aged 18-49 in the United States who are expecting a single child and did not conceive via IVF.
Restrictions: Excludes participants with fetal abnormalities, IVF pregnancies, or those using immunosuppressant medications; study may end by January 30, 2026.
Converts on successful completion of the medical screener and lead submission.
Targeting: Pregnant females aged 18-49 in the United States who are expecting a single child and did not conceive via IVF.
Restrictions: Excludes participants with fetal abnormalities, IVF pregnancies, or those using immunosuppressant medications; study may end by January 30, 2026.
Change log (1 events)
| Observed | Type | Field | Old | New |
|---|---|---|---|---|
| 7/6/2026 | offer_new | — | — | — |
Reviews (0)
No reviews yet — be the first to share your experience.
Log in or create a free account to review this offer.
Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.